MRK vs UNH
MRK: Merck & Co. is a leading global biopharmaceutical firm dedicated to delivering life-saving vaccines and innovative therapeutic medicines for major disease areas. UNH: UnitedHealth Group is a leading health care platform combining insurance coverage and clinical services to manage health costs and improve outcomes for millions of members.
Side-by-side fundamentals
| Metric | MRK | UNH | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $152.55 | $390.11 | |
| Market cap as of 2026-08-24 | $376.4B | $350.2B | |
| P/E as of 2026-08-24 | 103.86 | 25.63 | UNH lower |
| PEG as of 2026-08-24 | 4.91 | 2.39 | UNH lower |
| Net margin as of 2026-08-24 | +4.8% | +3.1% | MRK higher |
| Gross margin as of 2026-08-24 | +77.3% | n/a | |
| Operating margin as of 2026-08-24 | +9.6% | +4.7% | MRK higher |
| ROE as of 2026-08-24 | +17.9% | +14.4% | MRK higher |
| ROA as of 2026-08-24 | +7.0% | +4.5% | MRK higher |
| Debt / equity as of 2026-08-24 | 1.07 | 0.70 | UNH lower |
| Revenue growth (YoY) as of 2026-08-24 | +4.6% | +6.5% | UNH higher |
| Revenue CAGR (3y) SEC XBRL | +3.1% | +11.4% | UNH higher |
| Dividend yield as of 2026-08-24 | +2.9% | +1.4% | MRK higher |
| Dividend streak (yrs) SEC XBRL | 5 | 1 | MRK higher |
| Beta as of 2026-08-24 | 0.22 | 0.61 | |
| 1-year return as of 2026-08-21 close | +77.2% | +28.6% | MRK higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.